yl)uronium hexafluorophosphate (HBTU) coupling with SiR-COOH, to yield the Mer-inhibitor SiR-COOH conjugate (MERi-SiR) . Mer1: A solution of 2,4-dichloro-5-bromopyrimidine (1.8 g, 7.90 mmol), trans-4-aminocyclohexanol (937 mg, 6.18 mmol) and TEA (1.5 mL, 10.8 mmol) in iPrOH (30 mL) was stirred at ambient temperature for overnight. Next day, reaction mixture was concentrated in vacuo. Crude product was diluted with EtOAc and washed with water and brine. The organic layer was dried over Na2SO4 and concentrated in vacuo. Resulting crude product was diluted with 30 mL of EtOAc and 150 mL of hexane. 1, 159.6, 158.1, 106.4, 101.1, 95.9, 69.5, 48.9, 33.6, 30. 5, 151.0, 150.6, 126.0, 117.6, 88.6, 70.3, 53.3, 34.8, 31.3, 26.0, 18.3, -4.5 . 6, 152.0, 149.8, 121.0, 111.5, 88.3, 70.6, 52.6, 41.6, 35.0, 31.9, 30.9, 26.0, 20.3, 18.3, 14.0, -4.5 . 3, 153.4, 150.5, 136.4, 133.4, 130.0, 126.4, 118.6, 115.6, 110.3, 70.0, 62.9, 55.3, 53.3, 52.2, 46.2, 41.7, 34.8, 32.1, 30.8, 20 .4, 14.1. 3, 154.9, 153.3, 150.4, 135.9, 133.7, 129.8, 126.4, 118.7, 115.7, 110.2, 79.6, 70.7, 62.9, 53.0, 52.3, 41.6, 41.5, 35.1, 32.0, 30.9, 28.5, 26.0, 20.3, 18.3, 14.0, -4.5 . 
In vitro cell experiments:
SiRNA knockdown was performed using mouse and human SMARTpool ON-TARGET plus siRNA (referred to as "siMer") and ON-TARGET plus nontargeting siRNA #1 (referred to as "siControl"), all from GE Healthcare / Dharmacon (see Supplementary Table 1 for sequences). Transfection was performed using lipofectamine 3000 (Thermo) following manufacturer's guidelines. 500,000 cells were plated overnight in 10 cm dishes, transfected with 125 pmol siRNA, and assayed 72h later. To image competition of MERi-SiR with UNC2025, SK-MEL-3 were seeded overnight on 96-well plates (Ibidi), treated with UNC2025 or vehicle for 1.5 hr, then treated with the addition of MERiSiR at the indicated concentration, rinsed 3x in warm PBS 30 min later, and imaged 30 min later as described above using the BX63 microscopy system (Olympus).
In the above studies, cell fluorescence intensities were quantified by first segmenting regions of interest around individual cells (using ImageJ and CellProfiler software), calculating the average fluorescence intensities within each of these single-cell regions, and then averaging all cells together for each experiment. Vehicle controls were used to measure and subtract background autofluorescence. These background-subtracted data were routinely normalized to average values observed in the experimental conditions with the highest fluorescence, to yield "fraction max" measurements as in Fig. 2B , or to average values observed in the control (e.g., siControl) experimental conditions, to yield "fraction control" measurements as in Fig. 2C .
To image accumulation of MERi-SiR in comparison to α-Mer-Alexa488 antibody-dye conjugate (R&D Systems clone 125518), antibody buffer was first exchanged for PBS using a Zeba Spin
Desalting Column (Thermo/Fisher). SK-MEL-3 were seeded overnight on 96-well plates (Ibidi), treated with antibody at 1:100 dilution and 5μM MERi-SiR for 1h at 37 o C in full growth media, rinsed and treated with fresh media, and immediately imaged as described above using the BX63 microscopy system. To image total Mer, including intracellular cytoplasmic Mer, cells were fixed and permeabilized in 4% paraformaldehyde and 0.5% Triton-X 100 for 15 min at immediately imaged with Hoechst 33342 counterstaining. Radial profiles of MERi-SiR and α-Mer-Alexa488 were calculated in ImageJ using linear fluorescence intensity profile measurements drawn by hand, emanating radially from the edge of cell nuclei. Profiles were averaged across a cohort of cellular profiles (n>10) as a function of distance from cell nuclei.
Before averaging together, each fluorescence profile was normalized by subtracting the background and dividing the profile by the maximum pixel intensity observed on that profile. Gt anti-Rb IgG HRP secondary Ab was used (Thermo Cat. 31460, 1:10,000) with SuperSignal West Pico Chemiluminescent Substrate (Thermo).
In vivo experiments and ex vivo imaging: All animal research was performed in accordance with the guidelines from the Institutional Subcommittee on Research Animal Care. Experiments were performed 6-12 week old mice. Motivated by a previously published model of intraperitoneal carcinomatosis [Ripoll et al., 2010, Anticancer Res, 30, 5049-54] , 2 x 10 6 murine colorectal carcinoma cells (CT26; ATCC) stably expressing tdTomato transgene were intraperitoneally (i.p.) injected into MerTK GFP/+ NOD.CB17-Prkdc scid /J mice; males were used, as they may exhibit more hepatic metastases in this model [Sorski et al., 2014 , Surg Today, 44, 1925 . Roughly 10 days post-inoculation, 3 mg kg -1 MERi-SiR was i.p. injected from a 10 mM DMSO stock with 7 µl DMAC/solutol and 50 µl PBS. 24 h later animals were euthanized by CO2 chamber and metastases were immediately imaged after surgical excision. Animals were monitored daily and were euthanized once ascites developed or health deteriorated (body condition score 2 or less). Microscopy was performed on an Olympus FV1000 confocalmultiphoton imaging system using a XLUMPLFLN 20x water immersion objective (NA 1.0; Olympus America); 2x digital zoom; sequential scanning using 405-nm, 473-nm, 559-nm, and 635-nm diode lasers and a DM405/473/559/635-nm dichroic beam splitter; and collection of emitted light using beam splitters (SDM473, SDM560, and/or SDM 640) and emission filters BA430-455, BA490-540, BA575-620, and BA655-755 (all Olympus America).
Gross quantification of MERi-SiR accumulation across metastatic nodules was performed using an Olympus OV100 imaging system. Freshly excised tumor-bearing organs (liver, spleen) and lesions found within the abdominal cavity, for instance adhered to the omentum, were imaged 
